Mainstay Medical International Stock price Irish S.E.

Equities

MSTY1

IE00BJYS1G50

Advanced Medical Equipment & Technology

Delayed Irish S.E. 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Mainstay Medical International +6.44% -38.57%
Sales 2021 5.33M 4.94M Sales 2022 10.13M 9.39M Capitalization 29.71M 27.53M
Net income 2021 -35M -32.43M Net income 2022 -49M -45.41M EV / Sales 2021 -4.59 x
Net cash position 2021 54.15M 50.18M Net Debt 2022 102M 94.97M EV / Sales 2022 13 x
P/E ratio 2021
-0.85 x
P/E ratio 2022
-0.61 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 63.09%
More Fundamentals * Assessed data
Dynamic Chart
Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients CI
Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors CI
Mainstay Medical Holdings plc announced that it expects to receive funding CI
Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on Reactiv8® Restorative Neurostimulation Systemtm CI
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States CI
Mainstay Medical Holdings plc Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-Up Registry of Reactiv8 in the United Kingdom CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mainstay Medical Holdings plc Announces the Publication of Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact CI
Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Mainstay Medical Holdings plc Announces Publication of Two-Year Patient Outcomes Data from Reactiv8-B Clinical Trial Demonstrating Long-Term Efficacy of Reactiv8 Restorative Neurostimulation CI
Mainstay Medical Holdings plc Announces Appointment of Jeffrey Dunn and Eric Major to Its Board of Directors CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Mainstay Medical Announces Limited Announces Commercial Launch of ReActiv8® in US CI
Oxford Finance LLC Announces Closing of $50 Million Senior Secured Term Loan with Mainstay Medical Holdings plc CI
More news
Managers TitleAgeSince
Chief Executive Officer 52 17-10-08
Director of Finance/CFO 53 18-08-19
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 69 21-11-17
Chief Executive Officer 52 17-10-08
Director/Board Member 55 21-11-17
More insiders
  1. Stock
  2. Equities
  3. Stock Mainstay Medical International
  4. Stock Mainstay Medical International - Irish S.E.